← Leaderboards
Alexander Hillel
Johns Hopkins University
$7,431,714
Attributed
$8,089,085
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2015–25$2.5M$1.9M$1.3M$625K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,089,085 · 7
By mechanism
R01$4,934,354 · 3
UG3$1,314,743 · 1
K23$1,194,610 · 1
R21$491,250 · 1
R56$154,128 · 1
Top collaborators
- Alexander Gelbard1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Robert A. Wise$33,179,807
- Maureen Renee Horton$5,996,995
- Wayne Mitzner$20,452,046
- Kevin Motz$662,662
- David Wesley Dowdy$17,286,098
Others in their field
Top investigators on “Larynx”
- David Heimbrook · Leidos Biomedical Research, Inc.$89,819,252
- Kristina Simonyan · Massachusetts Eye And Ear Infirmary$21,046,460
- Ingo R Titze · Utah State Higher Education System--University Of Utah$17,322,533
- Jack J Jiang · Northwestern University$15,962,487
- Larry Arthur$15,377,757
- Donald C Bolser · University Of Florida$14,531,666
Research focus
LarynxMouse ModelCicatrixStenosisFibroblastsClinical PracticeIn VitroCommunication DisabilityMedicalTracheaHead And Neck SurgerySurgical ManagementMemberFacultyMedical SchoolsOtolaryngologyFibrosisBreathingPhenotypeCellsIn VivoRegenerative MedicineGene ExpressionStents
Grant awards (20)
1/2 ASTRO: Adjuvant STeRoid Outcomes in idiopathic subglottic stenosis: A randomized trial$1,314,743
UG3 · FY2025 · HL · contact PI
E-cadherin deficient epithelium drives airway fibrosis in idiopathic subglottic stenosis$752,541
R01 · FY2025 · HL · contact PI
Targeting mTOR regulation of T-lymphocytes and fibroblasts in Laryngotracheal Stenosis$698,928
R01 · FY2024 · DC · contact PI
Targeting mTOR regulation of T-lymphocytes and fibroblasts in Laryngotracheal Stenosis$711,127
R01 · FY2023 · DC · contact PI
Role of E-cadherin in epithelial barrier dysfunction and fibrosis in idiopathic subglottic stenosis$154,128
R56 · FY2023 · DC · contact PI
Targeting mTOR regulation of T-lymphocytes and fibroblasts in Laryngotracheal Stenosis$721,853
R01 · FY2022 · DC · contact PI
Targeting mTOR regulation of T-lymphocytes and fibroblasts in Laryngotracheal Stenosis$84,331
R01 · FY2022 · DC · contact PI
Targeting mTOR regulation of T-lymphocytes and fibroblasts in Laryngotracheal Stenosis$9,408
R01 · FY2022 · DC · contact PI
Targeting mTOR regulation of T-lymphocytes and fibroblasts in Laryngotracheal Stenosis$725,028
R01 · FY2021 · DC · contact PI
Immunotherapy induced Trm arrest and reverse lung fibrosis$409,375
R01 · FY2021 · HL · contact PI
Targeting mTOR regulation of T-lymphocytes and fibroblasts in Laryngotracheal Stenosis$84,888
R01 · FY2021 · DC · contact PI
Targeting mTOR regulation of T-lymphocytes and fibroblasts in Laryngotracheal Stenosis$736,875
R01 · FY2020 · DC · contact PI
Metabolic Reprogramming in Laryngotracheal Stenosis$163,750
R21 · FY2020 · DC · contact PI
Immune Cell Modulation in Laryngotrachael Fibrosis$238,922
K23 · FY2019 · DC · contact PI
Metabolic Reprogramming in Laryngotracheal Stenosis$163,750
R21 · FY2019 · DC · contact PI
Immune Cell Modulation in Laryngotrachael Fibrosis$238,922
K23 · FY2018 · DC · contact PI
Metabolic Reprogramming in Laryngotracheal Stenosis$163,750
R21 · FY2018 · DC · contact PI
Immune Cell Modulation in Laryngotrachael Fibrosis$238,922
K23 · FY2017 · DC · contact PI
Immune Cell Modulation in Laryngotrachael Fibrosis$238,922
K23 · FY2016 · DC · contact PI
Immune Cell Modulation in Laryngotrachael Fibrosis$238,922
K23 · FY2015 · DC · contact PI